PALADIN Consortium

In a recent?PharmaTalkRadio?podcast by The Conference Forum, PALADIN Executive Committee Co-chairs, Leonard Valentino?and Deirdre BeVard discuss how PALADIN is transforming the pace of medicine's development by equipping patient advocacy groups and biopharmaceutical/biotech companies with best practices, tools and resources for effective and efficient collaborations. Listen to the podcast episode here: https://lnkd.in/e4zQ3KZs Several PALADIN Consortium member organizations will be attending the Patients As Partners in Clinical Research Community News conference in Boston, March 17-19, 2025.?If you are attending and would like to connect, please reach out to Patricia Davidson, Tufts CSDD, PALADIN Consortium Director?to set up a time.

Please join us in welcoming LUNGevity Foundation to our?growing network of organizations. LUNGevity Foundation is firmly committed to making an immediate impact on increasing quality of life and survivorship of all people diagnosed with lung cancer—?a commitment that aligns with PALADIN’s mission to transform the pace of medicines’ development. Learn more about PALADIN's mission and view all member organizations here:?https://lnkd.in/gPk4H8M7 ?

Please join us in welcoming Teva Pharmaceuticals to our?growing network of organizations dedicated to transforming the pace of medicines development. Teva's commitment to finding new ways to make quality medicines more affordable and accessible to more people, serving nearly 200 million patients every single day will be invaluable as PALADIN continues to drive efficiencies in how patient advocacy groups?and industry collaborate. Learn more about PALADIN's mission and view all member organizations here: https://lnkd.in/gPk4H8M7

Thank you to all who attended Patricia Roselle's presentation at #SCOPESummit this morning! Pat's presentation shared insights on best practices for establishing efficient partnerships and the role the PALADIN consortium has played in optimizing PAG/Industry collaborations. Learn more at: https://lnkd.in/gPk4H8M7

If you're attending #SCOPESummit2025 next week, be sure to attend Patricia Roselle's presentation, Early Patient Advocacy Group Engagement: Best Practices for Establishing Efficient Partnerships on Tuesday, February 4th?at 11:05 am EST.? ? Pat will be sharing her insights as a founding member of the PALADIN Consortium on why collaboration between PAG/Industry is important and how to get partnerships up and running more efficiently. To learn more about PALADIN, visit: www.paladinconsortium.org

Please join us in welcoming?Johnson & Johnson Innovative Medicine ?to our?growing network of organizations dedicated to transforming the pace of medicines development. Their expertise?at blending heart, science, and ingenuity to redefine?healthcare?will be invaluable as PALADIN continues to drive efficiencies in how patient advocacy groups?and industry collaborate. ? Learn more about PALADIN's mission and view all member organizations here: https://lnkd.in/gPk4H8M7

Are you a Patient Advocacy Group (PAG) forming a new partnership with a pharmaceutical company or biotech? Are you a sponsor initiating a collaboration with a Patient Advocacy Group (PAG) and looking to align needs?? PALADIN has launched an Interactive Discussion Guide for your Patient Advocacy Group (PAG)-Industry Partnership?to provide helpful checklists, examples, and additional resources to ensure that partnership expectations are aligned from the outset of a collaboration. By structuring a discussion, this guide helps to optimize resource allocation and ensure partnerships are initiated and executed efficiently. View the Discussion Guide here: https://lnkd.in/dNdKzts3

Happy Holidays from the PALADIN Consortium! As we reflect on 2024, we are filled with gratitude for the collective efforts by?Patient Advocacy Groups and Industry to drive progress in transforming the pace of medicines development. This year, we’ve worked together to strengthen collaboration engagements, share best in class resources, and drive adoption of best practices for effective partnerships. As we enter the holiday season, PALADIN wishes you and your loved ones peace, happiness, and health. Here’s to a new year full of aspiration, effective collaboration, and meaningful impact in 2025!

We are excited to announce PALADIN’s Interactive Guide, designed to help the pharmaceutical industry and patient advocacy groups (PAGs) collaborate on the Target Product Profile (TPP)—a critical planning tool to facilitate communication with the FDA and stakeholders. The TPP streamlines drug development by defining the desired product characteristics for specific diseases. Incorporating PAG input ensures patient insights are integrated, leading to products that address real-world patient needs, improve safety, efficacy, usability, and overall patient outcomes. Co-developed by industry and PAGs, the PALADIN Interactive Guide includes key updates and resources to help navigate and foster effective and efficient TPP collaborations, ensure alignment, enhance the overall drug development process, and to transform the development journey towards more patient-centric healthcare solutions. To access the PALADIN interactive guide, visit: https://lnkd.in/eDuwZ_c4

The PALADIN Consortium is delighted to welcome Deirdre BeVard and Leonard Valentino as Executive Committee Co-Chairs. “We’re excited to be building on the momentum that Vicky DiBiaso created as PALADIN's Founding Executive Committee Chair in collaboration with PAGs and pharmaceutical company members,” said Len. “Our upcoming year promises continued impact on PAG-Industry partnerships to help transform the pace of new medicines development.” Deirdre added, “Our consensus-driven approach to optimize PAG-Industry collaboration is delivering valuable and useful resources and insights to the clinical research enterprise. Looking at the consortium's growth and progress to date, we are honored to advance PALADIN’s mission.” Deirdre and Len bring a wealth of expertise and commitment to advancing PALADIN’s mission.?Under their leadership, PALADIN is poised for an exceptional year of growth and achievement! For more information about PALADIN, visit?www.paladinconsortium.org?